Participated · Series B · Nov 2022

Fathom builds an autonomous medical coding platform that combines deep learning and natural language processing to enable health systems to deploy autonomous coding with automation across departments. The company states this implementation model delivers ROI with immediate operating margin impact. Led by CEO Andrew Lockhart and based in San Francisco, Fathom received a strategic investment from CVS Health Ventures. The company plans to use the funds to expand operations and accelerate development efforts. The article did not disclose revenue, user metrics, prior funding rounds, or valuation.